Evan R. Goldfischer, MD, MBA

Evan R. Goldfischer, MD, MBA

Premier Medical Group

Poughkeepsie, New York

Dr. Goldfischer is a urologist and Director of the Research Department at Premier Medical Group in Poughkeepsie, New York. He received his BA from Tufts University and his MD from Cornell University Medical College. He completed his Internship in General Surgery and his Residency in Urology at the University of Chicago. He then completed a Fellowship in Endourology under the direction of Arthur Smith at Long Island Jewish Medical Center. Dr. Goldfischer received his MBA from the University of Massachusetts and is a Certified Physician Executive. He is the Founder and Chair of the Board of Premier Cares Foundation, which aims to support and educate individuals who are unable to address significant issues like prostate and colon cancer. He has authored more than 100 peer-reviewed abstracts and publications and has lectured on six continents. Dr. Goldfischer has served as the Chair of the Advanced Prostate Cancer Expert Panel for the Public Education Council of the Urology Care Foundation, which is the official foundation of the AUA. He was elected to the LUGPA Board of Directors in 2014 and was elected Secretary of LUGPA in November 2018. Dr. Goldfischer was elected President of LUGPA in 2022 and still serves in that role.


Dr. Goldfischer has the following disclosures:
Research Support: Merck, Clovis, Janssen, Pfizer, Bayer, AbbVie
Speakers Bureau Member: Bayer, AbbVie, Janssen, Pfizer
Advisory Committee Member: Covis Pharma
Honorarium Recipient: Bayer, AbbVie, Janssen, Pfizer, Covis Pharma

Talks by Evan R. Goldfischer, MD, MBA

LUGPA Lecture: Urology Employment Issues

Panelists Dr. Evan Goldfischer, MD, MBA; Alan Walker, MHSA, FACMPE; and Allison Griffin discuss urology employment issues. Specifically, the panel covers physician recruitment, physician burnout and resilience, and staff recruitment and engagement, emphasizing employment paradigm shifts and creative, proactive solutions to today’s staffing challenges.

Read More

Negotiating Pay for Call Contracts with Hospitals

Evan R. Goldfischer, MD, MBA, FACS, urologist and Director of the Research Department at Premier Medical Group in Poughkeepsie, New York, discusses hospital service line agreements and the process of negotiating beneficial pay for call contracts. He begins by explaining physician health system alignment and how alignment can look different depending on how much autonomy a physician desires. Dr. Goldfischer explains that hospitals want to partner with urologists because they need urologic specialization for a wide variety of patients and do not know how to effectively manage service lines, and that urologists should desire partnership because it reduces the incentive for internal urology departments and gives urologists the opportunity to improve the condition of their practice. He also states that there is a great deal of benefit to patients due to access to well-trained and educated specialists. Dr. Goldfischer also describes how call coverage and quality improvement service arrangements function to benefit a hospital, and outlines the call coverage responsibilities, including 24/7 coverage 365 days a year, unassigned inpatients, daily rounds, and more. He then details call coverage compensation in terms of flat fee coverage. Dr. Goldfischer explains the variables involved in deciding flat fees such as extent of burden, extent of treatment, fair market value, and probability of providing uncompensated care. He details quality based payment strategies and how to collect evidence on the positive changes a physician has made as part of a hospital as a way to prove value. Dr. Goldfischer concludes by stating that physicians understand their specialty and should be compensated for achieving higher quality work and lower costs.

Read More

How to Optimize a Telehealth Visit

Evan R. Goldfischer, MD, MBA, FACS, urologist and Director of the Research Department at Premier Medical Group in Poughkeepsie, New York, and President-Elect of LUGPA, discusses how a medical practice can adapt to telehealth by adopting certain procedures for patients, doctors, and staff. He suggests that even if COVID-19 goes away, telehealth is here to stay because it produces high satisfaction rates amongst patients, is good for periods of inclement weather, can allow for weekend and evening billing of patient calls, can extend a practice to other regions, can be used for inpatient consults, and can be used for ER visits. Dr. Goldfischer acknowledges that working with new telehealth technology can be challenging for staff and recommends that staff are made familiar with the technology so that they in turn can instruct patients on its use. He also recommends that telehealth visits are scheduled during a dedicated block of time and aren’t interspersed with inpatient visits, that charts are prepped with all necessary lab results and notes, and that there is no need for a physical exam or any in-person sample collection. He also encourages video over audio visits. Dr. Goldfischer says that schedulers can help patients prepare for a telehealth visit by testing a patient’s ability to use the necessary technology and by having family members or nursing home staff present with the patient for the visit 10 minutes of the appointment. He suggests that doctors prepare by having 2 computers set up (1 for video and 1 for the electronic medical record), reviewing records ahead of time, being in a quiet and isolated room to preserve confidentiality, looking professional and not being distracted, and checking computer connectivity ahead of time. Dr. Goldfischer stresses the importance of focusing on the patient, engaging family members, taking in the patient’s surroundings, and making sure that the patient is engaged during the appointment. He recommends scheduling any follow-ups immediately after the visit and sending a letter or copy of the office notes if the doctor is unsure whether the patient processed all the information.

Read More

Managing a Clinical Research Program in 2020 (Updated)

Evan R. Goldfischer, MD, MBA, CPI, CPE, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, and Secretary of LUGPA, details how to effectively manage a clinical research program. He examines why clinical research is important and how it has changed over the years, with the biggest changes in 2020 being more training, more paperwork, and more time and difficulty negotiating budgets. Dr. Goldfischer discusses the importance of integrating the research program with the cancer clinic, as well as how the staff must work together to ensure a program’s success. He stresses the importance of clinical research involving everyone in the practice. In a follow-up Q&A with E. David Crawford, MD, Dr. Goldfischer discusses practical changes to research brought on by COVID-19.

Read More

Managing a Clinical Research Program in 2020

Evan R. Goldfischer, MD, MBA, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, discusses how those managing clinical research programs must adapt to new pressures in 2020. He notes that the increases in regulation and FDA oversight are challenges. He also details the necessary structure of research departments and processes for budget negotiation. By also describing possible pitfalls of clinical research programs, Dr. Goldfischer gives an encompassing overview of the process of clinical research program management.

Read More
  • 1
  • 2

Join the GRU Community

- Why Join? -